Intravenous Immunoglobulin (IVIg) Utilization in Immune Thrombocytopenia (ITP): A Multi-Center, Retrospective Review

INTRODUCTION: Intravenous immunoglobulin (IVIg) is an immune thrombocytopenia (ITP) therapy, which is associated with toxicities, limited availability, increasing utilization, and high cost. This study aimed to assess short- and long-term IVIg utilization in patients with ITP at two tertiary care ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsia, Cyrus C., Liu, Yang, Eckert, Kathleen, Monga, Neerav, Elia-Pacitti, Julia, Heddle, Nancy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883208/
https://www.ncbi.nlm.nih.gov/pubmed/27747610
http://dx.doi.org/10.1007/s40801-015-0009-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883208/
https://www.ncbi.nlm.nih.gov/pubmed/27747610
http://dx.doi.org/10.1007/s40801-015-0009-6

Ejemplares similares